Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ironshore Pharmaceuticals Closes on $143 Million of Financing to Launch ADHD Drug
Ironshore Pharmaceuticals Closes on $143 Million of Financing to Launch ADHD Drug
Ironshore Pharmaceuticals Closes on $143 Million of Financing to Launch ADHD Drug
Submitted by
admin
on August 23, 2018 - 9:53am
Source:
CP WIre
News Tags:
Ironshore Pharmaceuticals
Jornay PM
ADHD
Headline:
Ironshore Pharmaceuticals Closes on $143 Million of Financing to Launch ADHD Drug
snippet:
Proceeds will be used to launch Jornay PM
Jornay PM is a novel formulation of methylphenidate which is taken in the evening
Trials demonstrated improvement in the severity of ADHD symptoms in the early morning and throughout the day
Do Not Allow Advertisers to Use My Personal information
